Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 8.93
+0.22 (2.47%)
Sep 30, 2026, 4:08 PM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 5.93 billion as of September 30, 2026. Its market cap has decreased by -49.64% in one year.
Market Cap
5.93B
Enterprise Value
3.61B
Revenue
112.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.93
ChartMarket Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has decreased from 8.71B to 5.93B, a decrease of -31.97%. That is a compound annual growth rate of -7.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 5.93B | -32.25% |
| Dec 31, 2025 | 8.75B | 204.13% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | 8.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CStone Pharmaceuticals | 8.19B |
| Alphamab Oncology | 7.75B |
| LongBio Pharma (Suzhou) | 7.62B |
| Shanghai Haohai Biological Technology | 7.16B |
| Lepu Biopharma | 6.87B |
| CARsgen Therapeutics Holdings | 6.85B |
| Shaanxi Micot Pharmaceutical Technology | 6.60B |
| TenNor Therapeutics (Suzhou) | 5.99B |